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Edited by Lukas HuberAbstract Isoprenylation of geranylgeranyl-pyrophosphate
(GGPP) is critical for activation of small GTPases. We exam-
ined the roles of GGPP synthase (GGPPS) during the diﬀerenti-
ation induced by the cell-to-cell contact in osteoblastic cell line
MC3T3-E1 cells. We found that (1) both mRNA and protein
expression of GGPPS was reduced with decrement of its activity
during the diﬀerentiation, (2) GGOH, which is converted to
GGPP in the cells, inhibited diﬀerentiation. These results suggest
that the decrement of GGPP is critical for the cell-to-cell contact-
induced diﬀerentiation, in which the down-regulation of GGPPS
might be involved.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Diﬀerentiation1. Introduction
Mevalonate cascade has been demonstrated to be involved in
many biological phenomena such as proliferation and apopto-
sis in addition to diﬀerentiation, maturation and maintenance
of cellular functions. Mevalonate acts as a precursor of not only
cholesterol but also isoprenoids for farnesyl and geranylgeranyl
molecules, which have an important signaling function [1]. It
has been demonstrated that the ability of an HMG-CoA reduc-
tase inhibitor (statin) to interfere with proliferation through the
cell cycle progression and induce the apoptosis could be attrib-
uted to its activity in suppressing the isoprenylation of proteins
rather than interrupting of cholesterol synthesis [2,3].
Geranylgeranyl-pyrophosphate (GGPP) and farnesyl-pyro-
phosphate (FPP), two components of isoprenoids, were re-
ported to be major products of this pathway. The enzymes
that catalyze the covalent attachment to farnesyl and geranyl-
geranyl moieties to proteins like small GTPases are now well
characterized [1]. We have demonstrated that GGPP is an
essential compound through the activation of Rho small
GTPase for controlling the apoptosis in rat neurons [4] and*Corresponding author. Fax: +81 43 226 2095.
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doi:10.1016/j.febslet.2006.08.060the proliferation in rat astrocytes [5], rat thyroid FRTL-5 cells
[6–8], rat smooth muscle cells [9], human mesangial cells [10]
and human lymphocytes [11].
Bone is metabolically active and its organizational pattern of
the mineral and organic components determines the successful
mechanical integrity of the skeleton, which was achieved by a
dynamic balance between bone formation and bone resorp-
tion. In bone, bone-forming osteoblasts (Ob) and bone-resorb-
ing osteoclasts (Oc) are two of the major cells; calcitropic
hormones and cytokines control those [12–14]. Recently,
bisphosphonates (BPs) have been developed to inhibit the
bone-resorption in the treatment of osteoporosis, and their
molecular mechanism to inhibit the functions of Oc has been
largely revealed, with Luckman et al. demonstrating that both
FPP and GGPP prevent the apoptosis induced by not only
alendoronate, one of the nitrogen-containing BPs (NC-BP),
but also mevastatin, one of the statins, using mouse J774
macrophages as a surrogate for Oc [15]. Fisher at al. also showed
the importance of GGPP in the alendoronate-induced apopto-
sis by using mouse Oc [16]. In addition to their eﬀects on the
functions of Oc, both BP and statin were reported to aﬀect
the functions of Ob such as the diﬀerentiation [17,18]. For
example, pitavastatin, one of the statins, was demonstrated
to induce the diﬀerentiation in terms of mRNA expression of
bone morphogenetic protein-2 (BMP-2) and osteocalcin in a
GGPP-dependent manner [19]. These data indicated that the
mevalonic cascade regulates the functions of Oc and Ob
through the supply of GGPP.
GGPPS is critical for catalyzing the synthesis ofGGPP,which
is biosynthetically derived from the single condensation of FPP
and isopentenyl-pyrophosphate (IPP). The cDNA of human
GGPPSwas isolated from cDNA libraries of human fetal heart,
human hepatic cancer cell line JHH7 and human testis by others
and us [20–22]. Since it has been demonstrated that the mRNA
for GGPPS was expressed ubiquitously indicating the physio-
logical signiﬁcance of GGPP and GGPPS in many organs, this
might also be the case in bone metabolism. The mRNA expres-
sion, protein expression and activity of GGPPS were up-regu-
lated by the growth-stimulation during the proliferation in rat
FRTL5 thyroid cells [23]. It has been also reported that the pro-
tein expression ofGGPPS increased during the diﬀerentiation of
3T3-L1 ﬁbroblasts into adipocytes [24]. These reports suggest
that the protein expression and the activity of GGPPS may be
regulated in the proliferation and diﬀerentiation.blished by Elsevier B.V. All rights reserved.
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thase (GGPPS) during the diﬀerentiation induced by the cell-
to-cell contact in osteoblastic cell line MC3T3-E1 cells.2. Materials and methods
2.1. Reagents
Geranylgeraniol (GGOH), mercaptoethanol, alizarin red S and b-
glycerophosphate were purchased from Sigma Chemical Co. (St.
Louis, MO, USA). Cell culture media and reagents (a-modiﬁed mini-
mum essential medium [a-MEM], penicillin–streptomycin solution,
fetal bovine serum [FBS], trypsin 0.25% with EDTA 1 mM, nitrocellu-
lose) were obtained from Invitrogen Life Technologies (Carlsbad, CA,
USA). L-ascorbic acid was obtained from Wako Pure Chemical Co.
(Osaka, Japan). DULBECCO’S phosphate buﬀered saline [PBS] was
purchased from Dainippon Pharmaceutical Co. (Osaka, Japan). Aga-
rose was obtained from BioWhittaker Molecular Applications (Rock-
land, ME, USA). Antibodies against CyclinE, Cdk2, ALP (TNAP),
BMP-2 and Cbfa1 were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-p27Kip1 antibody was purchased from
Transduction Laboratories (Lexington, KY, USA). Mouse monoclo-
nal anti-b-actin was acquired from Sigma.2.2. Cell culture
Mouse monoclonal preosteoblast MC3T3-E1 cells were obtained
from RIKEN Cell Bank (Tsukuba, Japan). The cells were grown in
a-modiﬁed minimum essential medium (a-MEM) supplemented with
10% FBS and 1% penicillin–streptomycin solution (growing medium).
MC3T3-E1 cells were plated at a density of 5 · 104/cm2 to 6-well or
100 mm dishes, and then cultured at 37 C for diﬀerent periods under
5% CO2. After 24 h (it was designated as ‘‘day 0’’), MC3T3-E1 cells
were cultured in ‘‘diﬀerentiation medium’’ (a-MEM supplemented
with 0.2 mM L-ascorbic acid and 10 mM b-glycerophosphate) up to
36 days. The plates reached conﬂuence from 3 to 5 days of culture.
Culture medium was exchanged every 3 days.2.3. [3H]-thymidine incorporation assays
Cells cultured in triplicate in ‘‘growing medium’’ (control) or in ‘‘dif-
ferentiation medium’’ (days 3, 5, 7, 14), in 6-well plates. Cells were
incubated with 10 lCi/well [3H] thymidine (Perkin–Elmer Life Sci-
ences, Boston, MA, USA) for 24 h prior to harvest. Cells were ﬁxed
with 1 ml 5% trichloroacetic acid (TCA) for 20 min at 37 C, followed
by wash with 5% TCA. DNA was solubilized by incubation in 1 ml
0.5 N KOH for 24 h, and radioactivity was counted using 200 ll solu-
bilized DNA in 3 ml scintillation ﬂuid, and liquid scintillation counter.
2.4. Preparation of polyclonal antibody against human GGPPS
Rabbit polyclonal anti-human GGPPS antibody was made with
recombinant human GGPPS as we previously reported [23,25].
2.5. Protein preparation and western blot analysis
MC3T3-E1 cells were collected by centrifugation. The collected cells
were sonicated in cold lysis buﬀer as follows; 100 mM HEPES, pH 7.0,
300 mM NaCl, 2 mM EDTA, 5 mM EGTA, 0.1% Tween 20, 10%
glycerol, 1 mM sodium ﬂuoride, 0.1 mM sodium vanadate, and freshly
added protease inhibitor mixture Calbiochem, La Jolla, CA, USA. The
cells were allowed to lyse on ice for 60 min. For western blotting, the
20 lg of protein samples from each experiment were treated with
62.5 mM Tris–HCl buﬀer, pH 6.8, containing 2% SDS, 5% 2-mercap-
toethanol, 7% glycerol, and 0.01% bromophenol blue for 10 min in
boiling water, and each sample were subjected to SDS–PAGE
(12.5%). Western blotting was performed with anti-GGPPS, anti-
cyclin E, anti-cdk2 anti-p27Kip1, anti-TNAP, anti-BMP-2, or anti-b-
actin antibody using an enhanced chemiluminescence (ECL) Western
blotting kit (Amersham Bioscience Corp., Piscataway, NJ, USA).2.6. RT-PCR analysis
Oligonucleotide primers for RT-PCR were designed according to
published sequences. 5 0 primer: TGCCATTTGGTCAAGGCCAG
and 3 0 primer: TGAAGGGTTCCCACCACAGG generated a 193-bps fragment for mouse GGPPS. 5 0 primer: AGCTCAACAC-
CAATGTAGCC and 3 0 primer: CTTCACGCCACACAAGTAGG
generated a 233-bps fragment for mouse ALP2. 5 0 primer:
CTGCTCAGCATGTTTGGCCT and 3 0 primer: GAAGATCTGGA
GTTCTGCAGA generated a 291-bps fragment for mouse BMP-2.
5 0 primer: GGGGTGAGGCCGGTGCTGAGTAT and 3 0 primer:
CATTGGGGGTAGGAACACGGAAGG generated a 459-bps frag-
ment for mouse GAPDH. RNA was isolated from cultured cells using
by RNeasy Mini Kit (QIAGEN GmbH, Hilden, Germany). RT-PCR
was performed with by RNA PCR Kit (AMV) Ver.2.1 (TaKaRa Bio
Inc., Shiga, Japan) using 1 lg template of total RNA and speciﬁc prim-
ers for GGPPS, BMP-2, skeletal ALP and GAPDH. The samples were
run on a 1% agarose gel and photographed.
2.7. Activity of GGPPS
GGPPS activity was measured as reported previously [23,26].
Brieﬂy, it was determined in a 250 ll reaction containing 0.6 mM
MnCl2, 0.4 mM MgCl2, 0.36 lM FPP and 0.36 lM [
14C] IPP (50–
60 Ci/mmol). The reactions were started by the addition of 50 ll of cell
lysate (3 mg/ml protein) and allowed to proceed for 45 min at 30 C
(incubated in a water bath). The reactions were stopped by the addi-
tion of 500 ll of butanol. The samples were vortexed for 10 s, and cen-
trifuged at 2000 rpm for 5 min in order to separate the organic and
aqueous phases. The amount of [14C]-GGPP produced was determined
by the amount of radioactivity in 250 ll of the butanol phase, since
GGPP, not FPP and IPP, is organic to move to the butanol phase.
2.8. Alizarin red S staining
MC3T3-E1 cells were cultured for 28 days. The cells were washed
twice with PBS then ﬁxed with 4% paraformaldehyde in PBS, pH
7.4. The ﬁxed MC3T3-E1 cells were stained with 1% alizarin red S
solution. The areas of the mineralized nodules stained with alizarin
red S were scanned and converted into TIFF images. These images
were analyzed with National Institutes of Health Image 1.63 software
on a G4 Macintosh computer as previously reported [27].
2.9. Statistical analysis
Statistical diﬀerences within each experiment were determined by
analysis of variance, and diﬀerences between groups were calculated
by the Student’s t-test. A rejection level of P < 0.05 was considered sig-
niﬁcant. This analysis was carried out on a personal computer using
the ‘‘StatView J4.02’’ software statistical package (Abacus Concepts,
Inc., Berkeley, CA, USA).3. Results
3.1. Eﬀect of cell-to-cell contact on the proliferation and
diﬀerentiation in the osteoblastic MC3T3-E1 cells
MC3T3-E1 osteoblastic cells were cultured in 100 mm
dishes, and reached conﬂuence from day 3 to 5 of culture.
The cell-to-cell contacts of MC3T3-E1 cells were observed to
begin from day 2 to 3 under a microscope. The proliferation
of MC3T3-E1 cells was estimated by [3H]-thymidine incorpo-
ration and cell counting assay (data not shown) with the
expression of cell cycle regulators.
Its proliferation was inhibited in a time-dependent manner.
In [3H]-thymidine incorporation assays, 95% reduction was
observed at day 5 (Fig. 1A). The analysis of cell regulators
with the western blot analysis demonstrated the protein expres-
sion of p27Kip1, a negative cell cycle regulator at G1/S transi-
tion, increased and the protein expressions of both Cdk2 and
Cyclin E, two of positive regulators at G1/S transition, de-
creased in a time-dependent manner (Fig. 2B).
The diﬀerentiation of MC3T3-E1 cells was determined by
the mRNA and protein expressions of ALP, a marker of osteo-
blast. The mRNA expression of ALP and protein expressions
of ALP and BMP-2 increased after the cell-to-cell contact in a
time-dependent manner (Fig. 2A, B), and the extra-cellular
Fig. 2. The change of mRNA and protein expression of GGPPS, and its activity in the cell-to-cell contact-induced diﬀerentiation of MC3T3-E1 cells:
(A) The mRNA expression of GGPPS and ALP; the mRNA expressions of GGPPS and ALP were determined by RT-PCR analysis as described in
Section 2. (B) The protein expressions of GGPPS, cell cycle regulator (Cdk2, CyclinE, p27Kip1), and mouse bone ALP and BMP-2 in the osteoblastic
MC3T3-E1 cells diﬀerentiation originated by cell-to-cell contact; the protein expressions of these molecules were determined by western blot analysis
as described in Section 2. These data shown were representatives of three independent experiments. (C) The change of GGPPS activity in MC3T3-E1
cells; Each GGPPS activity in the cell-to-cell contact-induced diﬀerentiation of MC3T3-E1 cells was measured as described in Section 2. These data
presented were representatives of three independent experiments.
Fig. 1. Eﬀect of cell-to-cell contact in the proliferation and mineralization of osteoblastic MC3T3-E1 cells: (A) [3H]-thymidine incorporation assays;
MC3T3-E1 cells were pulsed for 24 h with [3H] thymidine, and incorporated radioactivity was quantiﬁed. Results are presented as CPM per protein
(±standard error) from three independent experiments. (B) Time course analysis of the mineralization of MC3T3-E1 cells; mineralization was
determined by alizarin red S staining, and the area of calciﬁcation was measured by ‘‘NIH image’’ as described in Section 2. Results shown are
representative of three independent experiments.
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the cell-to-cell contact in MC3T3-E1 cells (Fig. 1B).
3.2. Roles of GGPP and GGPPS in the cell-to-cell contact-
induced diﬀerentiation in MC3T3-E1 cells
We examined the roles of GGPP and GGPPS in the prolif-
eration and diﬀerentiation of MC3T3-E1 cells by cell-to-cell
contact. Both mRNA and protein expressions of GGPPS were
observed at day 0, and the cell-to-cell contact signiﬁcantly
decreased both its mRNA and protein expressions in a time-
dependent manner (Fig. 2A, B). Its activity was also attenu-
ated after the cell-to-cell contact in a manner similar to those
of both their mRNA and protein expressions (Fig. 2C).
3.3. Eﬀect of GGOH in the cell-to-cell contact-induced
osteoblastic diﬀerentiation
We examined the role of GGOH, which is converted to
GGPP in the cells [28], in the diﬀerentiation of MC3T3-E1 cellsinduced by cell-to-cell contact. GGOH treatment inhibited the
increment of p27Kip1 induced by cell-to-cell contact in MC3T3-
E1 cells. In addition, the presence of GGOH signiﬁcantly
inhibited the diﬀerentiation of MC3T3-E1 cells induced by
cell-to-cell contact in terms of increasing protein expressions
of ALP, BMP-2, and the extracellular mineralization
(Fig. 3A, B).4. Discussion
In the present study, we examined the roles of GGPPS and
GGPP in the calciﬁcation of Ob using MC3T3-E1 cells which
diﬀerentiate to osteocytic cells by cell-to-cell contact as a
model [29–31]. We have chosen MC3T3-E1 cell line because
it provides useful in vitro system to study the regulation signals
in relation to the diﬀerent stages from proliferation to mineral-
ization.
Fig. 3. Eﬀect of GGOH on the diﬀerentiation and mineralization of
osteoblastic MC3T3-E1 cells: (A) The eﬀect of GGOH on the protein
expression of p27Kip1, mouse bone ALP, BMP-2 in the diﬀerentiation
of MC3T3-E1 cells. MC3T3-E1 cells were grown in the ‘‘diﬀerentiation
medium’’ with or without 10 lM of GGOH for 7 days. The protein
expressions of these molecules were determined by western blot
analysis as described in Section 2. These data shown were represen-
tatives of three independent experiments. (B) The eﬀect of GGOH on
the osteoblastic mineralization. MC3T3-E1 cells were treated with or
without GGOH (10 lM) for 28 days. Culture medium and GGOH
in 6-well plate of MC3T3-E1 cells were exchanged every 3 days.
Mineralization was determined by alizarin red S staining, and the
area of calciﬁcation was measured by ‘‘NIH image’’ as described in
Section 2. Results shown are representative of three independent
experiments. *P < 0.05 vs. Control.
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compound through the activation of Rho small GTPase to in-
duce the proliferation in many types of cells [5,6,8–11], and
Ohnaka et al. reported that GGPP suppress the diﬀerentiation
of human Ob through the activation of Rho and Rho-kinase
[19]. These results indicate that GGPP may directly induce
osteoblastic proliferation and may inhibit the diﬀerentiation
and/or mineralization, and also the concentration of GGPP
may be critical for osteoblastic proliferation and diﬀerentia-
tion. Then, we postulated that GGPPS regulating GGPP pro-
duction might be controlled by the cell-to-cell contact in the
diﬀerentiation of MC3T3-E1 cells. The objective of this work
is to determine whether the concentration of GGPP and also
the changes in GGPPS activity involve the cell-to-cell con-
tact-induced response of Ob.
We thus examined the regulation of GGPPS in the diﬀeren-
tiation of MC3T3-E1 cells induced by cell-to-cell contact. The
cell-to-cell contact inhibited the proliferation followed by the
diﬀerentiation in terms of the mRNA expression of ALP,
and protein expressions of ALP and BMP-2 (Fig. 2A, B),
and mineralization of extra-cellular matrix in a time-dependent
manner in MC3T3-E1 cells. During the diﬀerentiation, the
mRNA and the protein expressions, and the activity of
GGPPS substantially decreased (Fig. 2A, B). This may indi-
cate that the cell-contact suppressed the mRNA expression
and activity of GGPPS to decrease the production of GGPP,
and this response inhibited the proliferation and promoted
the diﬀerentiation of Ob. Actually, the presence of GGOH,
which is converted to GGPP in the cells, prevented the
MC3T3-E1 cells from being diﬀerentiated by the cell-contact
(Fig. 3A, B).
Both Ob and adipocytes are well known to be originated
from mesenchymal stem cells. The diﬀerentiation of adipocytes
and that of Ob are supposed to be the two sides of the samecoin, since mouse myoblastic C2C12 cell, a mesenchymal stem
cell line, is diﬀerentiated into Ob by the addition of BMP-2
[32], but diﬀerentiated into adipoblasts by adipogenic inducers,
such as thiazolidinediones or fatty acids [33]. Recently, Vicent
et al. demonstrated that the expression of GGPPS is regulated
in multiple tissues, and is induced during adipocyte diﬀerenti-
ation [24]. Therefore, the regulation of GGPPS might be
important for the diﬀerentiation of mesenchymal stem cells
between Ob and adipocytes. In the proliferation of eukaryotic
cells, cell cycle progression is controlled by the sequential acti-
vation of cyclin dependent kinases (Cdk). Cdk activation is
dependent on the formation of cyclin/Cdk complexes. Cdk
inhibitors, such as ink4 and Cip/Kip family proteins, play roles
as negative regulators of the cell cycle progression; the forma-
tion of cyclin–Cdk complexes stimulates the kinase activity of
Cdk that is negatively regulated by speciﬁc Cdk inhibitors
(ckis). The expression of cyclin E and the formation of the
cyclin E/Cdk2 complex followed by the kinase activation of
Cdk2 are one of the essential events in cell cycle progression
from late G1 to S phase. Kinase activity is governed by
p27Kip1 during this transition from late G1 to S phase. In a
rat thyroid cell line of FRTL-5 cells, we demonstrated that ger-
anylgeranylation of Rho small GTPase(s) by GGPP during
G1/S transition is critical for promoting the degradation of
p27Kip1 without any eﬀect of its synthesis, which induces cell
cycle progression in FRTL-5 cells [6]. It is also the case in
the cell-to-cell contact-induced diﬀerentiation since it is
GGPP-dependent and the protein expression of p27Kip1 in-
creased with the decrement of the protein expressions of both
Cdk2 and Cyclin E during the diﬀerentiation.
Proteins undergoing prenylation include Ras and Ras-
related small GTP-binding proteins, such as Cdc42, Rho,
Rab, Rac, the c subunit of the trimetric G proteins, and others.
Ohnaka et al. reported that pitavastatin, one of the HMG-
CoA reductase inhibitors, stimulated the expression level of
mRNA for BMP-2 and osteocalcin, and fasudil also stimulated
the mRNA expression of BMP-2 and osteocalcin [19]. These
data suggest that the down-regulation of GGPPS is vital to
the osteoblastic mineralization probably through the inhibi-
tion of the activation of prenylated protein, such as Rho small
GTPases followed by the inactivation of Rho kinase.
In the present study, we used MC3T3-E1 cell line as a model
to study the regulation signals in relation to the diﬀerent stages
from proliferation to mineralization. Since MC3T3-E1 cell line
is a murine transformed osteoblastic cell line and needs several
speciﬁc conditions such as the presence of ascorbic acid and b-
glycerophosphate to diﬀerentiate, further studies must be con-
ducted to elucidate the roles of GGPPS in the physiological
bone formation.
In summary, the cell-contact inhibited the proliferation and
induced the diﬀerentiation with the decrement of both mRNA
expression and activity of GGPPS, and GGPP inhibited the
cell contact-induced diﬀerentiation and mineralization in
MC3T3-E1 cells. These results may indicate that (1) GGPP/
Rho signal stimulates osteoblastic proliferation; (2) the activity
of GGPPS is down-regulated by the cell-contact in the Ob; (3)
and the regulation of GGPPS is supposed to be critical for the
diﬀerentiation of Ob supposedly through the inactivation of
Rho-Rho kinase pathway.Acknowledgements: We thank Ms. K. Suzuki, and Ms. M. Maemori
for their excellent assistance.
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